Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 7.11M | 21.97M | 25.93M | -13.10M | -17.30M |
| Total Depreciation and Amortization | 88.60K | 94.50K | 85.60K | 63.30K | 45.00K |
| Total Amortization of Deferred Charges | 498.80K | 456.00K | 388.80K | 326.40K | 281.40K |
| Total Other Non-Cash Items | -9.03M | -24.05M | -28.03M | 10.89M | 15.09M |
| Change in Net Operating Assets | 389.10K | 338.20K | 211.80K | 72.60K | 21.70K |
| Cash from Operations | -942.00K | -1.19M | -1.41M | -1.74M | -1.86M |
| Capital Expenditure | -62.30K | -66.90K | -87.10K | -39.10K | -40.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.80K | -118.50K | -230.00K | -254.50K | -242.50K |
| Cash from Investing | -40.50K | -185.40K | -317.10K | -293.60K | -283.20K |
| Total Debt Issued | 1.13M | 1.40M | 1.83M | 2.39M | 2.43M |
| Total Debt Repaid | -446.60K | -311.60K | -290.30K | -265.40K | -241.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 251.30K | 251.30K | 194.00K | -- | 0.00 |
| Cash from Financing | 937.80K | 1.34M | 1.73M | 2.13M | 2.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.70K | -40.00K | 5.20K | 91.00K | 44.80K |